All In Biotech

Free tool

FAERS Monitor: Vascepa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202057 or its brand name (Vascepa, Icosapent Ethyl). Reports on generic versions are filed under their own applications.

Reports

8,228

Serious

2,986

36% of reports

Hospitalization

1,368

Death reported

422

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • product odour abnormal1,055
  • product physical issue915
  • off label use675
  • poor quality product administered668
  • diarrhoea525
  • nausea504
  • product taste abnormal451
  • drug ineffective450
  • arthralgia399
  • fatigue350
  • blood triglycerides increased305
  • eructation281
  • prescribed underdose257
  • dizziness242
  • headache240

Reports by year received

View as table
YearReports
20111
20125
201375
2014102
2015208
2016207
2017350
2018391
2019659
2020939
20211,176
2022801
2023772
2024759
2025952
2026831

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,931 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product odour abnormalSignal1,055286.2269.6269,535
poor quality product administeredSignal668172.9160.4106,832
product physical issueSignal915121.4114.0104,291
product taste abnormalSignal45188.080.437,458
blood triglycerides increasedSignal30544.940.212,831
eructationSignal28137.733.59,854
prescribed underdoseSignal25733.329.57,936
arthralgiaSignal3992.52.2349
diarrhoeaSignal5252.11.9302
off label use6752.01.8336
nausea5041.61.5126
dizziness2421.21.111
fatigue3501.11.07
headache2401.00.90
drug ineffective4500.90.89

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.